Hetero
India - HyderabadBiotechnology
Focus: Hetero is a public biotechnology company headquartered in Hyderabad, India, specializing in APIs, generics, and biosimilars across infectious diseases, oncology, and other therapeutic areas. The company operates a mature, diversified portfolio of off-patent drugs with significant revenue concentration in cardiovascular generics.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Hetero
AI assessmentNot HiringNo open roles listed right now. Follow Hetero to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
1 in 5yr
HYFTOR
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$91M Part DStable
Post-LOE
Flagship product representing 69% of company revenue; mature generic with sustained demand in cardiovascular market.
Help build intelligence for Hetero
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.